KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Idexx Laboratories (IDXX) Shares Outstanding (Diluted Average): 2009-2024

Historic Shares Outstanding (Diluted Average) for Idexx Laboratories (IDXX) over the last 14 years, with Dec 2024 value amounting to $83.2 million.

  • Idexx Laboratories' Shares Outstanding (Diluted Average) fell 2.72% to $81.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $81.2 million, marking a year-over-year decrease of 2.72%. This contributed to the annual value of $83.2 million for FY2024, which is 0.87% down from last year.
  • Idexx Laboratories' Shares Outstanding (Diluted Average) amounted to $83.2 million in FY2024, which was down 0.87% from $84.0 million recorded in FY2023.
  • Over the past 5 years, Idexx Laboratories' Shares Outstanding (Diluted Average) peaked at $86.7 million during FY2020, and registered a low of $83.2 million during FY2024.
  • For the 3-year period, Idexx Laboratories' Shares Outstanding (Diluted Average) averaged around $83.9 million, with its median value being $84.0 million (2023).
  • Data for Idexx Laboratories' Shares Outstanding (Diluted Average) shows a maximum YoY dropped of 2.28% (in 2022) over the last 5 years.
  • Over the past 5 years, Idexx Laboratories' Shares Outstanding (Diluted Average) (Yearly) stood at $86.7 million in 2020, then dropped by 0.17% to $86.6 million in 2021, then dropped by 2.28% to $84.6 million in 2022, then decreased by 0.74% to $84.0 million in 2023, then declined by 0.87% to $83.2 million in 2024.